Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABG Innovation-Quantum is a specialized life sciences investment and venture creation firm that focuses on bridging the gap between academic research and commercial drug development. The company identifies high-potential early-stage assets and platforms, particularly in oncology and rare diseases, and provides the necessary capital and operational expertise to advance them through the pre-clinical stage. By leveraging a network of scientific advisors and strategic partners, ABG Innovation-Quantum aims to accelerate the delivery of transformative therapies to patients. Their portfolio typically includes a mix of internal venture-built projects and external investments in innovative biotech startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ABG Innovation-Quantum.